Search Results

• • 19 

    Academic Journals

  • Sort by: sorttype.publication.date.desc Newest sorttype.publication.date.asc Oldest sorttype.relevance Relevance

• Nutrient Sensor mTORC1 Regulates Insulin Secretion by Modulating (beta)-Cell Autophagy.

  Authors:Tal Israeli, Yael Riahi, Perla Garzon, Ruy Andrade Louzada, Joao Pedro Werneck-de Castro, Manuel Blandino-Rosano, et al.From:Diabetes (Vol. 71, Issue 3) Peer-Reviewed

  Mar. 2022 Report

   Citation Only

• Endosomal Sequestration of TLR4 Antibody Induces Myeloid-Derived Suppressor Cells and Reverses Acute Type 1 Diabetes.

  Authors:Kathryn C.S. Locker, Kritika Kachapati, Yuehong Wu, Kyle J. Bednar, David Adams, Caroline Patel, et al.From:Diabetes (Vol. 71, Issue 3) Peer-Reviewed

  Mar. 2022 Report

   Citation Only

• The Need to Increase Clinical Skills and Change the Genetic Testing Strategy for Monogenic Diabetes.

  Authors:Rosa Di Paola, Antonella Marucci, and Vincenzo TrischittaFrom:Diabetes (Vol. 71, Issue 3) Peer-Reviewed

  Mar. 2022 Article

   Citation Only

• Imeglimin Ameliorates (beta)-Cell Apoptosis by Modulating the Endoplasmic Reticulum Homeostasis Pathway.

  Authors:Jinghe Li, Ryota Inoue, Yu Togashi, Tomoko Okuyama, Aoi Satoh, Mayu Kyohara, et al.From:Diabetes (Vol. 71, Issue 3) Peer-Reviewed

  Mar. 2022 Report

   Citation Only

• Recessive Genome-Wide Meta-analysis Illuminates Genetic Architecture of Type 2 Diabetes.

  Authors:Mark J. O'Connor, Philip Schroeder, Alicia Huerta-Chagoya, Paula Cortes-Sanchez, Silvia Bonas-Guarch, Marta Guindo-Martinez, et al.From:Diabetes (Vol. 71, Issue 3) Peer-Reviewed

  Mar. 2022 Report

   Citation Only

• Gene Panel Sequencing of Patients With Monogenic Diabetes Brings to Light Genes Typically Associated With Syndromic Presentations.

  Authors:Cecile Saint-Martin, Delphine Bouvet, Mathilda Bastine, and Christine Bellanne-ChantelotFrom:Diabetes (Vol. 71, Issue 3) Peer-Reviewed

  Mar. 2022 Report

   Citation Only

• Functional Gly297Ser Variant of the Physiological Dysglycemic Peptide Pancreastatin Is a Novel Risk Factor for Cardiometabolic Disorders.

  Authors:Prasanna K.R. Allu, Malapaka Kiranmayi, Sromona D. Mukherjee, Venkat R. Chirasani, Richa Garg, Durairajpandian Vishnuprabu, et al.From:Diabetes (Vol. 71, Issue 3) Peer-Reviewed

  Mar. 2022 Report

   Citation Only

• ATP-Sensitive Potassium Channels in Hyperinsulinism and Type 2 Diabetes: Inconvenient Paradox or New Paradigm?

  Authors:Colin G. Nichols, York. Nathaniel W., and Maria S. RemediFrom:Diabetes (Vol. 71, Issue 3) Peer-Reviewed

  Mar. 2022 Article

   Citation Only

• Syndromic Monogenic Diabetes Genes Should Be Tested in Patient With a Clinical Suspicion of Maturity-Onset Diabetes of the Young.

  Authors:Kevin Colclough, Sian Ellard, Andrew Hattersley, and Kashyap PatelFrom:Diabetes (Vol. 71, Issue 3) Peer-Reviewed

  Mar. 2022 Report

   Citation Only

• Imeglimin to the Rescue: Enhanced CHOP/GADD34/eIF2(alpha) Signaling Axis Promotes (beta)-Cell Survival.

  Authors:Seokwon Jo and Emilyn U. AlejandroFrom:Diabetes (Vol. 71, Issue 3) Peer-Reviewed

  Mar. 2022 Article

   Citation Only

• The Role of TRAP(gamma)/SSR3 in Preproinsulin Translocation into the Endoplasmic Reticulum.

  Authors:Xiaoxi Xu, Yumeng Huang, Xin Li, Peter Arvan, and Ming LiuFrom:Diabetes (Vol. 71, Issue 3) Peer-Reviewed

  Mar. 2022 Report

   Citation Only

• Seroactivity Against Tyrosine Phosphatase PTPRN Links Type 2 Diabetes and Colorectal Cancer and Identifies a Potential Diagnostic and Therapeutic Target.

  Authors:Maria Garranzo-Asensio, Guillermo Solis-Fernandez, Ana Montero-Calle, Jose Manuel Garcia-Martinez, Maria Carmen Fiuza, Pilar Pallares, et al.From:Diabetes (Vol. 71, Issue 3) Peer-Reviewed

  Mar. 2022 Report

   Citation Only

• Obesity-Induced miR-455 Upregulation Promotes Adaptive Pancreatic (beta)-Cell Proliferation Through the CPEB1/CDKN1B Pathway.

  Authors:Qianxing Hu, Jinming Mu, Yuhong Liu, Yue Yang, Yue Liu, Yi Pan, et al.From:Diabetes (Vol. 71, Issue 3) Peer-Reviewed

  Mar. 2022 Report

   Citation Only

• Adipose Issue Inflammation Is Not Related to Adipose Insulin Resistance in Humans.

  Authors:Ana Elena Espinosa De Ycaza, Esben Sondergaard, Maria Morgan-Bathke, Kelli Lytle, Danae A. Delivanis, Paola Ramos, et al.From:Diabetes (Vol. 71, Issue 3) Peer-Reviewed

  Mar. 2022 Report

   Citation Only

• Tolerogenic Delivery of a Hybrid Insulin Peptide Markedly Prolongs Islet Graft Survival in the NOD Mouse.

  Authors:Braxton L. Jamison, James E. DiLisio, K. Scott Beard, Tobias Neef, Brenda Bradley, Jessica Goodman, et al.From:Diabetes (Vol. 71, Issue 3) Peer-Reviewed

  Mar. 2022 Report

   Citation Only

• SGLT2 Inhibition Increases Fasting Glucagon but Does Not Restore the Counterregulatory Hormone Response to Hypoglycemia in Participants With Type 1 Diabetes.

  Authors:Schafer C. Boeder, Justin M. Gregory, Erin R. Giovannetti, and Jeremy H. PettusFrom:Diabetes (Vol. 71, Issue 3) Peer-Reviewed

  Mar. 2022 Report

   Citation Only

• Cytotoxicity-Related Gene Expression and Chromatic Accessibility Define a Subset of CD4+ T Cells That Mark Progression to Type 1 Diabetes.

  Authors:Naiara G. Bediaga, Alexandra L. Garnham, Gaetano Naselli, Esther Bandala-Sanchez, Natalie L. Stone, Joanna Cobb, et al.From:Diabetes (Vol. 71, Issue 3) Peer-Reviewed

  Mar. 2022 Report

   Citation Only

• Clinical Predictors and Long-term Impact of Acute Kidney Injury on Progression of Diabetic Kidney Disease in Chinese Patients With Type 2 Diabetes.

  Authors:Guozhi Jiang, Andrea O. Luk, Claudia H.T. Tam, Risa Ozaki, Cadmon K.P. Lim, Elaine Y.K. Chow, et al.From:Diabetes (Vol. 71, Issue 3) Peer-Reviewed

  Mar. 2022 Report

   Citation Only

• A Cycle of Inflammatory Adipocyte Death and Regeneration in Murine Adipose Tissue.

  Authors:Akio Monji, Yang Zhang, G.V. Naveen Kumar, Christelle Guillermier, Soomin Kim, Benjamin Olenchock, et al.From:Diabetes (Vol. 71, Issue 3) Peer-Reviewed

  Mar. 2022 Report

   Citation Only